This company listing is no longer active
TTBL.F Stock Overview
Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Total Brain Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.012 |
52 Week High | US$0.035 |
52 Week Low | US$0.012 |
Beta | 1.37 |
11 Month Change | -0.83% |
3 Month Change | -0.83% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -95.56% |
Recent News & Updates
Recent updates
Shareholder Returns
TTBL.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | -3.7% | -2.1% |
1Y | n/a | 2.8% | 30.2% |
Return vs Industry: Insufficient data to determine how TTBL.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how TTBL.F performed against the US Market.
Price Volatility
TTBL.F volatility | |
---|---|
TTBL.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.0% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TTBL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TTBL.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | Matt Mund | www.totalbrain.com |
Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors.
Total Brain Limited Fundamentals Summary
TTBL.F fundamental statistics | |
---|---|
Market cap | US$267.44k |
Earnings (TTM) | -US$9.97m |
Revenue (TTM) | US$4.29m |
0.4x
P/S Ratio-0.2x
P/E RatioIs TTBL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TTBL.F income statement (TTM) | |
---|---|
Revenue | AU$6.34m |
Cost of Revenue | AU$10.01m |
Gross Profit | -AU$3.67m |
Other Expenses | AU$11.05m |
Earnings | -AU$14.72m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.11 |
Gross Margin | -57.96% |
Net Profit Margin | -232.30% |
Debt/Equity Ratio | 0% |
How did TTBL.F perform over the long term?
See historical performance and comparison